Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance-Reference-Cited by-同舟云学术

Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance

Published:2018-01-24 Issue:5 Volume:73 Page:1158-1166
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Malet Isabelle¹²,Ambrosio Francesca A³,Subra Frédéric⁴,Herrmann Béatrice⁴,Leh Hervé⁴,Bouger Marie-Christine⁴,Artese Anna³,Katlama Christine⁵,Talarico Carmine³,Romeo Isabella³,Alcaro Stefano³,Costa Giosuè³,Deprez Eric⁴,Calvez Vincent¹²,Marcelin Anne-Geneviève¹²,Delelis Olivier⁴

Affiliation:

1. Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), 75013 Paris, France

2. Department of Virology, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France

3. Department of Health Sciences, University “Magna Græcia” of Catanzaro, Viale Europa, 88100 Catanzaro, Italy

4. LBPA, ENS Cachan, CNRS UMR8113, IDA FR3242, Université Paris-Saclay, F-94235 Cachan, France

5. Department of Infectious Diseases, Hôpital Pitié Salpetriere, Paris, France

Funder

ANRS

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/5/1158/24609956/dkx529.pdf